KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Novavax (NVAX) Other Gross PP&E Adjustments (2016 - 2025)

Novavax has reported Other Gross PP&E Adjustments over the past 15 years, most recently at $46.8 million for Q4 2025.

  • Quarterly results put Other Gross PP&E Adjustments at $46.8 million for Q4 2025, down 67.34% from a year ago — trailing twelve months through Dec 2025 was $46.8 million (down 67.34% YoY), and the annual figure for FY2025 was $46.8 million, down 67.34%.
  • Other Gross PP&E Adjustments for Q4 2025 was $46.8 million at Novavax, down from $143.3 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for NVAX hit a ceiling of $325.0 million in Q4 2023 and a floor of -$108.7 million in Q3 2022.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$106000.0 (2021), compared with a mean of $64.0 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: surged 35.53% in 2021 and later plummeted 102477.36% in 2022.
  • Novavax's Other Gross PP&E Adjustments stood at $226.8 million in 2021, then rose by 7.6% to $244.1 million in 2022, then soared by 33.16% to $325.0 million in 2023, then crashed by 55.9% to $143.3 million in 2024, then tumbled by 67.34% to $46.8 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $46.8 million (Q4 2025), $143.3 million (Q4 2024), and $325.0 million (Q4 2023) per Business Quant data.